Heplisav B Eiropas Savienība - latviešu - EMA (European Medicines Agency)

heplisav b

dynavax gmbh - hepatīta b virsmas antigēns - b hepatīts - vakcīnas - heplisav b is indicated for the active immunisation against hepatitis b virus infection (hbv) caused by all known subtypes of hepatitis b virus in adults 18 years of age and older. the use of heplisav b should be in accordance with official recommendations. it can be expected that hepatitis d will also be prevented by immunisation with heplisav b as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection.

Hepar compositum N šķīdums injekcijām Latvija - latviešu - Zāļu valsts aģentūra

hepar compositum n šķīdums injekcijām

biologische heilmittel heel gmbh, germany - aknu to cyanocobalaminum, divpadsmitpirkstu zarnas to thymus savas resnās zarnas to urīnpūšļa fellea to aizkuņģa dziedzeris to pieneņu officinale, lycopodium clavatum, chelidonium lielāks, skābes oroticum monohydricum, mizas pubescens, silybum marianum, histaminum, sēru, auzas sativa, nātrija diethyloxalaceticum, skābes alfa-ketoglutaricum, skābes malicum, skābes fumaricum, calcium carbonicum hahnemanni, skābes dl alfa-liponicum, cynara scolymus, veratrum album - Šķīdums injekcijām